PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,091.00
-67.00 (-5.79%)
At close: May 20, 2026
PeopleBio Revenue
In the year 2025, PeopleBio had annual revenue of 2.85B KRW with 12.64% growth.
Revenue
2.85B
Revenue Growth
+12.64%
P/S Ratio
9.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.85B | 319.91M | 12.64% |
| Dec 31, 2024 | 2.53B | -1.92B | -43.17% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hanil Chemical Ind. | 124.41B |
| East Asia Holdings Investment | 70.54B |
| Jolse | 64.22B |
| JK Synapse | 61.93B |
| Barrel | 59.19B |
| PN Poong Nyun | 56.04B |
| HK Co., Ltd. | 54.19B |
| Vitzrosys. | 44.81B |